|
|
|
Insider
Information: |
Dreyer Scott |
Relationship: |
EVP & Chief Commercial... |
City: |
Canton |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
1 |
|
Direct
Shares |
105,902 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,509,592 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
105,902 |
|
|
Total
Value |
$3,509,592 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
2
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-2.0
|
Percentage
Gain/Loss : |
0.0%
|
-9.4%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Collegium Pharmaceutical, Inc |
COLL |
EVP & Chief Commercial... |
2024-05-24 |
105,902 |
2018-07-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
37 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
|
2023-01-09 |
4 |
AS |
$27.08 |
$488,554 |
D/D |
(17,834) |
102,798 |
0 |
% |
|
COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
|
2023-02-10 |
4 |
D |
$26.75 |
$570,471 |
D/D |
(21,326) |
148,206 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
|
2023-02-10 |
4 |
A |
$0.00 |
$0 |
D/D |
66,734 |
169,532 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
|
2023-03-01 |
4 |
AS |
$26.70 |
$355,751 |
D/D |
(13,324) |
134,882 |
0 |
% |
|
COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
|
2024-01-16 |
4 |
AS |
$32.28 |
$760,519 |
D/D |
(23,560) |
111,322 |
0 |
% |
|
COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
|
2024-02-12 |
4 |
D |
$33.70 |
$1,000,553 |
D/D |
(29,690) |
148,918 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
|
2024-02-12 |
4 |
A |
$0.00 |
$0 |
D/D |
67,286 |
178,608 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
|
2024-02-26 |
4 |
AS |
$36.38 |
$364,270 |
D/D |
(10,000) |
138,918 |
0 |
% |
|
COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
|
2024-05-23 |
4 |
S |
$33.82 |
$1,732,093 |
D/D |
(51,209) |
138,918 |
0 |
% |
|
COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
|
2024-05-23 |
4 |
OE |
$24.03 |
$1,230,552 |
D/D |
51,209 |
190,127 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
|
2024-05-24 |
4 |
OE |
$24.03 |
$571,698 |
D/D |
23,791 |
162,709 |
0 |
- |
|
COLL |
Collegium Pharmaceutical,... |
EVP & Chief Commercial Officer |
|
2024-05-24 |
4 |
S |
$33.98 |
$1,930,455 |
D/D |
(56,807) |
105,902 |
0 |
% |
|
37 Records found
|
|
Page 2 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|